Home Supplements How We Rate Blog
Epimedium

Horny Goat Weed

Research reviewed: up until 03/23

Horny Goat Weed (Epimedium) is a dietary supplement with 6 published peer-reviewed studies involving 175 participants, researched for Erectile functions, Postmenopausal symptoms.

6
Studies
175
Participants
2004–2010
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Moderate Evidence

Erectile functions

Weak
4 studies 2 of 4 positive 0 participants 0 human

Postmenopausal symptoms

Moderate
2 studies 1 of 2 positive 175 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

2/6
Randomised
2/6
Double-Blind
2/6
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2010)
0
Study 2 (2005)
0
Study 3 (2004)
0
Study 4 (2006)
0
Study 1 (2008)
90
Study 2 (2007)
85

Research Timeline

When the studies were published

1
2004
1
2005
1
2006
1
2007
1
2008
1
2010

All Studies

Detailed breakdown of each trial. Click to expand.

Erectile functions

1

To evaluate the effects of icariin (icariin is the main active component of horny goat weed) on penile blood flow and tissues in cavernous nerve-injured rats (the cavernous nerve is the main autonomic nerve that regulates penile erection).

2010 4 weeks 1, 5, and 10 mg/kg of icariin
Animal Study Positive

Study Type

Rats with erectile dysfunction due to nerve injury

Purpose

To evaluate the effects of icariin (icariin is the main active component of horny goat weed) on penile blood flow and tissues in cavernous nerve-injured rats (the cavernous nerve is the main autonomic nerve that regulates penile erection).

Dose

1, 5, and 10 mg/kg of icariin

Duration

4 weeks

Results

Daily treatment with low-dose icariin for 4 weeks improved penile blood flow dynamics in rats. Compared to the control, the researchers detected significantly higher neuronal nitric oxide synthase in the penile tissue. This is an enzyme that helps to generate nitric oxide which initiates penile erections. More specifically, nitric oxide is needed for the muscles in the penis to relax. This relaxation allows chambers inside the penis to fill with blood so the penis becomes erect. Conclusion: This study indicates that icariin (found in horny goat weed) may improve penile blood flow. Penile blood flow is essential for erections. Clinical studies are needed to investigate its efficacy in humans.

Read full study
2

To investigate the effect of icariin on erectile function and the expression of nitric oxide synthase* in castrated rats.*Nitric oxide synthase generates nitric oxide that initiates penile erections.

2005 4 weeks 1 mg/kg/day and 5 mg/kg/day
Animal Study Positive

Study Type

Rats with erectile dysfunction due to nerve injury

Purpose

To investigate the effect of icariin on erectile function and the expression of nitric oxide synthase* in castrated rats.*Nitric oxide synthase generates nitric oxide that initiates penile erections.

Dose

1 mg/kg/day and 5 mg/kg/day

Duration

4 weeks

Results

Several markers of erectile function improved in most treatment groups: In 2 out of 3 treatment groups, the expression (activation) of two forms of nitric oxide synthase significantly improved in the erectile tissue of rats. Note that nitric oxide synthase generates nitric oxide which initiates penile erections. In 1 of the treatment groups, phosphodiasterase-5 was significantly decreased. Note that phosphodiesterase-5 interferes with blood flow to the penis that is needed for an erection. Conclusion: Oral treatment with icariin for 4 weeks potentially improves erectile function in rodents.

Read full study
3

To investigate the effects of orally administered icariin on the expression (levels) of nitrogen oxide synthase* in the erectile tissue of rats with erectile dysfunction.

2004 30 days 5 mg/kg/day or 10 mg/kg/day
Animal Study Mixed

Study Type

Rats with erectile dysfunction

Purpose

To investigate the effects of orally administered icariin on the expression (levels) of nitrogen oxide synthase* in the erectile tissue of rats with erectile dysfunction.

Dose

5 mg/kg/day or 10 mg/kg/day

Duration

30 days

Results

Chronic oral treatment with icariin increases erectile function and restores nitric oxide synthase* in the erectile tissue of rats.

Read full study
4

To investigate the effect of icariin on phosphodiesterase-5

2006
Animal Study Mixed

Study Type

Laboratory study

Purpose

To investigate the effect of icariin on phosphodiesterase-5

Results

Icariin exhibited inhibitory effects on all forms of phosphodiesterase-5.

Read full study

Postmenopausal symptoms

1

To evaluate the effects of dried Epimedium extract on blood lipid levels and sex hormone levels (estradiol, progesterone and testosterone). Background information: Horny goat weed contains phytoestrogens, compounds that act like the hormone estrogen.

2008 90 participants 6 months 300mL of hot water Epimedium extract (with 25% icariin)
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled clinical trial

Purpose

To evaluate the effects of dried Epimedium extract on blood lipid levels and sex hormone levels (estradiol, progesterone and testosterone). Background information: Horny goat weed contains phytoestrogens, compounds that act like the hormone estrogen.

Dose

300mL of hot water Epimedium extract (with 25% icariin)

Participants

90 postmenopausal women

Duration

6 months

Results

Epimedium water extract was associated with a significant increase in blood levels of estradiol (an estrogen hormone) compared with the pre-treatment level. It was also associated with a significant decrease in total cholesterol and total triglyceride levels.

Read full study
2

To investigate the effect of the phytoestrogen flavonoids derived from Epimedium brevicornum maxim (horny goat weed) on bone loss in postmenopausal women.

2007 85 participants 24 months 60mg icariin (with 15mg Daidzein and 3mg Genistein) paired w...
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomised, double-blind, placebo-controlled clinical trial

Purpose

To investigate the effect of the phytoestrogen flavonoids derived from Epimedium brevicornum maxim (horny goat weed) on bone loss in postmenopausal women.

Dose

60mg icariin (with 15mg Daidzein and 3mg Genistein) paired with 300mg elemental calcium daily

Participants

85 healthy late postmenopausal women

Duration

24 months

Results

Phytoestrogen flavonoids from horny goat weed were associated with preventative effects on bone loss in late postmenopausal women.

Read full study

Frequently Asked Questions

Common questions about Horny Goat Weed research

What does the research say about Horny Goat Weed?

There are currently 6 peer-reviewed studies on Horny Goat Weed (Epimedium), involving 175 total participants. Research covers Erectile functions, Postmenopausal symptoms. The overall evidence strength is rated as Moderate.

How strong is the evidence for Horny Goat Weed?

The evidence is currently rated as "Moderate Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (2 human studies, 4 animal studies), and reported outcomes.

What health goals has Horny Goat Weed been studied for?

Horny Goat Weed has been researched for: Erectile functions, Postmenopausal symptoms. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Horny Goat Weed based on human trials?

Yes, 2 out of 6 studies are human trials. The remaining 4 are animal studies. Human trials carry more weight in our evidence scoring system.